FINANCIAL STATEMENTS

FOR THE QUARTER ENDED

31st March 2024

SINGHE HOSPITALS PLC

(PB 70371 PQ)

Singhe Hospitals PLC

INCOME STATEMENT & STATEMENT OF OTHER COMPREHENSIVE INCOME Period Ended,

31-Mar-2024

31-Mar-2023

Rs.

Rs.

Not Audited

Audited

Revenue

1,271,872,929

1,071,705,911

Cost of Services

(484,164,596)

(461,081,926)

Gross Profit

787,708,333

610,623,985

Other Income and Gains

1,829,547

1,789,544

Administrative Expenses

(600,516,228)

(468,644,034)

Other Operating Expenses

(99,419,229)

(62,969,286)

Finance Cost

(57,497,181)

(64,852,753)

Profit Before Tax

32,105,242

15,947,457

Income Tax

(32,186,390)

(5,594,590)

Profit/(Loss) for the Period

(81,148)

10,352,867

Items That Will Not be Reclassified to Profit or Loss

Actuarial Gain/(Loss) from Valuation of Defined Benefit Plans

(2,851,854)

(460,383)

Gain on Revaluation of Land & Building

Deferred Tax Impact on Defined Benefit Plan Actuarial Gain/(Loss)

570,371

64,454

Gain on Revaluation of Property Plant & Equipment

378,247,579

-

Deferred Tax Impact on Revaluation Gain

(75,649,516)

-

Other Comprehensive Income/ (Expenses)

300,316,580

(395,929)

Total Comprehensive Income/ (Loss) for the Period

300,235,432

9,956,938

Earnings/(Loss) Per Share - Basic

(0.00)

0.02

2

Singhe Hospitals PLC

INCOME STATEMENT & STATEMENT OF OTHER COMPREHENSIVE INCOME

Three Months Ended,

31-Mar-2024

31-Mar-2023

Rs.

Rs.

Not Audited

Not Audited

Revenue

317,693,191

301,099,258

Cost of Services

(137,640,185)

(156,107,013)

Gross Profit

180,053,007

144,992,245

Other Income and Gains

(494,716)

(1,134,027)

Administrative Expenses

(153,063,300)

(108,891,463)

Other Operating Expenses

(7,729,083)

(20,146,027)

Finance Cost

(9,600,704)

(18,583,335)

Profit Before Tax

9,165,204

(3,762,606)

Income Tax

13,660,868

410,864

Profit/(Loss) for the Period

22,826,071

(3,351,742)

Other Comprehensive Income/ (Expenses)

Actuarial Gain/(Loss) from Valuation of Defined Benefit Plans

(2,851,854)

-

Gain on Revaluation of Land & Building

-

Deferred Tax Impact on Defined Benefit Plan Actuarial Gain/(Loss)

570,371

-

Gain on Revaluation of Property Plant & Equipment

378,247,579

-

Deferred Tax Impact on Revaluation Gain

(75,649,516)

-

Other Comprehensive Income/ (Expenses)

300,316,580

-

Total Comprehensive Income/ (Expenses)

323,142,651

(3,351,742)

Earnings/(Loss) Per Share - Basic

0.05

(0.01)

3

Singhe Hospitals PLC

STATEMENT OF FINANCIAL POSITION

As at,

31-Mar-2024

31-Mar-2023

ASSETS

Rs.

Rs.

Not Audited

Audited

Non-Current Assets

Property, Plant and Equipment

1,107,195,534

730,156,297

Right of Use Assets

67,914,375

54,362,082

Intangible Assets

11,836,754

6,462,625

1,186,946,663

790,981,004

Current Assets

Inventories

65,018,751

110,357,773

Trade and Other Receivables

53,952,925

44,795,323

Financial Investments

27,235

28,265

Short Term Investment

13,902,268

12,000,000

Cash and Bank Balances

30,498,151

23,030,636

163,399,329

190,211,997

Total Assets

1,350,345,992

981,193,001

EQUITY AND LIABILITIES

Capital and Reserves

Stated Capital

375,000,000

375,000,000

Capital Reserves

409,695,432

109,378,852

Retained Earnings

19,863,026

19,944,174

Total Equity

804,558,458

504,323,026

Non-Current Liabilities

Interest Bearing Loans and Borrowings

147,243,753

165,781,071

Lease Liability

26,887,440

16,717,516

Deferred Tax Liabilities

168,023,751

71,186,926

Retirement Benefit Obligations

16,432,268

11,872,980

358,587,213

265,558,494

Current Liabilities

Trade and Other Payables

72,072,644

95,122,656

Interest Bearing Loans and Borrowings

66,790,782

60,127,987

Lease Liability

17,792,568

17,058,267

Bank Overdrafts

21,379,965

34,797,921

Taxation

9,164,363

4,204,650

187,200,322

211,311,481

Total Equity and Liabilities

1,350,345,992

981,193,001

0

Net Assets Per Share

1.87

1.17

The above figures are provisional & subject to audit.

It is certified that the Financial Statements have been prepared in accordance with the requirements of the Companies Act No.7 of 2007.

Sgd.

Asanka De Silva

Finance Manager

The Board of Directors are responsible for the preparation and presentation of these Financial Statements. Approved & Signed on behalf of the Board.

Sgd.

Sgd.

Navinda Weerasinghe

Lakshika Weerasinghe

Managing Director

Director

29.05.2024

Rathnapura

4

Singhe Hospitals PLC

STATEMENT OF CHANGES IN EQUITY

Period Ended 31st March 2024

Stated

Revaluation

Gain / ( Loss) on

Retained

Capital

Reserves

Defined Benefit Plan

Earnings

Total

Rs.

Rs.

Rs.

Rs.

Rs.

Balance as at 01st April, 2022

375,000,000

106,242,881

3,531,900

9,591,307

494,366,088

Profit for the Period

-

-

-

10,352,867

10,352,867

Other Comprehensive Income

-

-

(460,383)

-

(460,383)

Deferred Tax Impact on Actuarial Gain/(Loss)

-

-

64,454

-

64,454

Balance as at 31st March, 2023

375,000,000

106,242,881

3,135,971

19,944,174

504,323,026

Profit for the Period

-

-

-

(81,148)

(81,148)

Other Comprehensive Income

-

378,247,579

(2,851,854)

-

375,395,725

Deferred Tax Impact on Actuarial Gain/(Loss)

-

-

570,371

-

570,371

Deferred Tax on Revaluation

-

(75,649,516)

-

-

(75,649,516)

Balance as at 31st March, 2024

375,000,000

408,840,944

854,488

19,863,026

804,558,458

5

Singhe Hospitals PLC

CASH FLOW STATEMENT

Year Ended,

31-Mar-2024

31-Mar-2023

Cash Flows From Operating Activities

Rs.

Rs.

Profit/(Loss) Before Income Tax Expense

32,105,242

15,947,457

Adjustments for

Depreciation & Amortization

73,700,330

76,488,443

Provision for Retirement Gratuity

4,625,094

3,807,386

Finance Expense

57,497,181

64,852,753

Interest Income

(1,499,274)

(1,112,332)

Bad debts written off

751,455

57,416

Fair Value (Gain)/Loss on Quoted Investments

1,030

(7,545)

Stocks Written Off

3,778,358

-

Operating Profit Before Working Capital Changes

170,959,415

160,033,578

Changes in Working Capital

(Increase)/Decrease in Inventories

41,560,658

(25,407,788)

Increase/(Decrease) in Amount Due to Related Parties

-

(672,111)

(Increase)/Decrease in Trade and Other Receivables

(9,909,057)

(6,229,085)

Increase/(Decrease) in Trade and Other Payables

(23,050,012)

57,066,395

Cash Generated From Operations

179,561,004

184,790,989

Income Tax Paid

(5,425,290)

-

Finance Costs Paid

(57,497,181)

(64,852,753)

Defined Benefit Plan Costs Paid

(2,917,660)

(2,450,056)

WHT Paid

(43,708)

(25,206)

Net Cash From Operating Activities

113,677,165

117,462,972

Cash Flows From/(Used in) Investing Activities

Acquisition of Property, Plant and Equipment

(42,436,447)

(40,168,451)

Acquisition of Capital Work in Progress

(3,951,140)

(2,162,948)

Acquisition of Capital Work in Progress - Intangible Assets

(3,128,500)

(70,000)

Acquisition of Intangible Assets

(3,857,483)

(750,000)

Acquisition of Right of Use Assets

(38,044,837)

(8,899,024)

Income From Investments - Interest Received

1,499,274

1,112,332

Investment in Fixed Deposit

(1,902,268)

(12,000,000)

Net Cash Flows From/(Used in) Investing Activities

(91,821,401)

(62,938,091)

Cash Flows from /(Used in) Financing Activities

Net Proceeds from Interest Bearing Borrowings

(11,874,523)

(9,118,045)

Proceeds from Leases

45,915,525

12,665,493

Repayments of Leases Liability

(35,011,297)

(31,498,967)

Net Cash Flows from/(Used in) Financing Activities

(970,295)

(27,951,519)

Net Increase/(Decrease) in Cash and Cash Equivalents

20,885,470

26,573,363

Cash and Cash Equivalents at the Beginning of the Year

(11,767,284)

(38,340,647)

Cash and Cash Equivalents at the End of the Year

9,118,186

(11,767,284)

Cash & Cash Equivalents

Cash at Bank

17,693,143

3,265,877

Bank Overdrafts

(21,379,965)

(34,797,921)

Cash in Hand

12,805,008

19,764,760

Cash and Cash Equivalents at the End of the Year

9,118,186

(11,767,284)

6

Singhe Hospitals PLC

NOTES TO THE INTERIM FINANCIAL STATEMENTS

01. Singhe Hospitals PLC ("Company") is a quoted public Company with limited liability incorporated in Sri Lanka under the provisions of Companies Act No. 07 of 2007. Its registered office and principal place of business are located at No: 362, Colombo Road, Rathnapura.

02. The interim condensed financial statements have been prepared in accordance with Sri Lanka Accounting Standard - LKAS 34 Interim Financial Reporting. These interim condensed financial statements should be read in conjunction with the annual financial statements for the year ended 31 March 2023. These financial statements provide the information as required in terms of Rule 7.4 of the Colombo Stock Exchange. Further , Provisions of the Companies Act No 7 of 2007 have been considered in preparing the interim financial statements of the Company.

03. Figures disclosed in the interim financial statements are provisional and subject to audit.

04. The presentation and classification of the Financial Statements of the previous year have been amended, where relevant, for better presentation and to be comparable with those of the current year.

05. The Interim Condensed Financial Statements of the Company for the period ended 31st March 2024 were authorised for issue by the Board of Directors on 29.05.2024

06. Issued and fully paid number of Ordinary Shares as at 31st March 2024 stands at 431,300,895.

07. There were no material commitments outstanding as at 31st March 2024 for future capital expenditure.

08. There were no material events that occurred after the reporting date that require adjustments or disclosure to the Financial Statements. Other than above.

  1. There were no significant changes in the nature of the contingent liabilities and contingent assets which were disclosed in the Annual Report for the year ended 31st March 2023.
  2. There have been no other events, which require disclosure in the Interim Financial Statements.
  3. The key management personnel of the company are the members of its Directors.

Key Management Personnel Compensation

As at

As at

31st March 2024

31st March 2023

Short Team Employee Benefit

1,746,000

1,746,000

Post Employment Benefits

Nil

Nil

Interest Bearing Loan And Borrowings

As at

As at

31st March 2024

31st March 2023

Bank Term Loan with in One year

66,790,782

60,127,987

Bank Term Loan after One year

147,243,753

165,781,071

Bank Term Loan

214,034,535

225,909,058

7

Singhe Hospitals PLC

NOTES TO THE INTERIM FINANCIAL STATEMENTS

As at

As at

31st March 2024

31st March 2023

No of Ordinary Shares

431,300,895

431,300,895

Market Value of Shares

As at

As at

Date

31st March 2024

31st March 2023

Highest Price per Share - Rs.

28.03.2024

2.40

3.00

Lowest Price Per Share - Rs.

18.03.2024

2.10

2.50

Last Traded Price per Share - Rs.

28.03.2024

2.30

2.60

Directors Shareholding

Name Of Director

As at

As at

31st March 2024

31st March 2023

Mr. A.M. Weerasinghe

372,697,415

372,697,415

Mr. A.M.D.H.N.Weerasinghe

10

10

Mr. A.M.L.M. Weerasinghe

50,000

50,000

Mr. U.B.H.J. Kithsiri

1,100,000

1,100,000

373,847,425

373,847,425

Public Holding Information

As at

As at

31st March 2024

31st March 2023

Issued Share Capital

431,300,895

431,300,895

Less

Directors Shareholding

373,847,425

373,847,425

Related Party Company

285,074

285,074

Public Holding

57,168,396

57,168,396

Public Holding as a percentage of Issued Share Capital

13.25%

13.25%

Number of Public Shareholders

1,418

1,376

Percentage of Total Public Holding

13.25%

13.25%

Major Shareholdings

Twenty Largest Shareholders

As at

%

As at

%

Name of the Shareholder

Country of Residence

31st March 2024

31st March 2023

01

Mr. A. M. Weerasinghe

Sri Lanka

372,697,415

86.41%

372,697,415

86.41%

02

Hatton National Bank PLC/Almas Holdings (PVT) LTD

Sri Lanka

14,831,860

3.44%

18,231,720

4.23%

03

DFCC Bank PLC/G.A.C De Silva

Sri Lanka

5,480,000

1.27%

5,345,875

1.24%

04

Mr.A.S. Jayasinghe

Sri Lanka

0.49%

05

Hatton National PLC/Madhura Supun Hiripitiya

Sri Lanka

0.37%

06

Mr. K. K. D. P. A. P. Weligepola

Sri Lanka

0.35%

07

Mr. A.M.C.S Atapattu

Sri Lanka

4,406,379

1.02%

2,990,049

0.69%

08

Mr.A.S. Jayasinghe

Sri Lanka

2,133,599

0.49%

2,133,599

0.49%

09

Assetline Finance Limited/M. S. Hiripitiya

Sri Lanka

1,631,248

0.38%

1,920,534

0.45%

10

Mr. K. K. D. P. A. P. Weligepola

Sri Lanka

1,497,101

0.35%

1,497,101

0.35%

11

Mr. W.A.S.P. De Saram

Sri Lanka

1,378,759

0.32%

1,430,363

0.33%

12

Mr. U.B.H.J. Kithsiri

Sri Lanka

1,100,000

0.26%

1,100,000

0.26%

13

Hatton National Bank PLC/A. P. Lasantha Fernando

Sri Lanka

1,100,000

0.26%

1,000,000

0.23%

14

Senkadagala Finance PLC/Mr. S. Gobinath

Sri Lanka

1,000,000

0.23%

999,998

0.23%

15

Techtron Intergrated Solutions (PVT) LTD

Sri Lanka

893,430

0.21%

793,430

0.18%

16

Mr. G.P.D.M. Pathiraja

Sri Lanka

808,151

0.19%

654,780

0.15%

17

Mr. D.F.H.K. Perera

Sri Lanka

539,896

0.13%

18

Mr. P.R. De Silva

Sri Lanka

528,256

0.12%

19

Dr. G.S.Perera

Sri Lanka

511,224

0.12%

511,224

0.12%

20

Mr. K. B. Kannangara

Sri Lanka

500,000

0.12%

500,000

0.12%

21

Dialog Finance PLC/M.M.S. Asela

Sri Lanka

487,674

0.11%

22

Hatton National Bank PLC/Ravindra Erle Rambukwelle

Sri Lanka

480,000

0.11%

480,000

0.11%

23

Mr. L. E. Liyanage

Sri Lanka

436,000

0.10%

24

Mr. P.R. De Silva

Sri Lanka

528,256

0.12%

443,521

0.10%

25

Mr. L. E. Liyanage

Sri Lanka

436,000

0.10%

26

Mr. D.R.K. Jayawardana

Sri Lanka

377,989

0.09%

27

Mr. D.U.J. Jayawardana

Sri Lanka

364,000

0.08%

28

Mr. G.P.D.M. Pathiraja

Sri Lanka

Total

412,969,248

95.76%

413,907,598

97.18%

The Float- adjusted market capitalization as at 31st March is Rs. 131,487,310 and the Company is in compliance with option 2 of the Listing Rules 7.13.1 (b) which requires 10% minimum public holding percentage and 200 minimum public shareholders.

8

Singhe Hospitals PLC

Corporate Information

Name of the Company

SINGHE HOSPITALS PLC

Register Office

362,Colombo Road,Ratnapura.

Telephone Number

0457 555 555

Email Address

info@singhehospitals.com

Web Address

www.singhehospital.com

Incorporation Number

PB 70371 PQ

Date of Incorporation

2009 December 16

Board of Directors

Mr. A.M. Weerasinghe

Mr.A. M. D. H. Navinda Weerasinghe

Mr.U. B. H. Jayalath Kithsiri

Mr.A. M. L. Maduranga Weerasinghe

Mr.H.M.A.B. Weerasekara

Mr.A.M.A.Cader

Mr.A. M. P. N. Weerasinghe

Mr. D.T. Gooneratne - (Has resigned on 18th April 2024)

Dr. A.C. Jayakody

Secretary to Company

Nexia Corporate Consultant (Pvt) Ltd

No. 130, 2nd Floor, Nawala Road,

Narahenpita,

Colombo 5.

Auditors

BR De Silva & Company,

22/4, Vijaya Kumaranatunga Mawatha,

Colombo 5.

Banks

Bank of Ceylon

Commercial Bank of Ceylon PLC

Hatton National Bank PLC

Sampath Bank PLC

Nation Trust Bank

Registrars

SSP Corporate Servicers (Pvt) Ltd

546/7, Galle Road,

Colombo 03.

9

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Singhe Hospital plc published this content on 29 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 May 2024 09:43:00 UTC.